WisdomTree International Hedged Quality Dividend Growth Fund에 대한 매도 수량은 투자자에게 WisdomTree International Hedged Quality Dividend Growth Fund의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

WisdomTree International Hedged Quality Dividend Growth Fund (ARCA:IHDG), 공매도 수량 보고

WisdomTree International Hedged Quality Dividend Growth Fund

WisdomTree International Hedged Dividend Growth Fund

Consumer Cyclical

Healthcare

Industrials

Technology

Basic Materials

Consumer Defensive

Financial Services

Communication Services

Utilities

Real Estate

Energy

Other

The fund will invest at least 80% of its total assets in component securities of the index and investments that have economic characteristics that are substantially identical to the economic characteristics of such component securities. The index consists of dividend-paying common stocks with growth characteristics of companies in the industrialized world, excluding Canada and the U.S., while at the same time neutralizing exposure to fluctuations of the value of foreign currencies relative to the USD. It is non-diversified.

Lvmh Moet Hennessy Louis Vuitton Se

Industria De Diseno Textil S.A.

Asml Holding N.V.

Astrazeneca Plc

Novartis AG 

Novo Nordisk A/S B Common Stock Dkk.1

Deutsche Post Ag

State Street Navigator Securities Lending Government Money Market Portfolio

Tokyo Electron Ltd

Government

Long Ideas

Regulations

Broad U.S. Equity ETFs

Exclusives

Trading Ideas

Interview

ETFs

iShares Dow Jones Select Dividend Index Fund

IEFA

IHDG

초저금리의 시대는 완전히 지나갔다. 위즈덤트리(WisdomTree)의 주식 전략 책임자 제프 웨니거(Jeff Weniger)는 투자자들에게 분명한 메시지를 전했다. &#34;10년 만기 국채 수익률이 4%대 초반이면 S&amp;P 500 지수 수익률은 무위험 수익률을 간신히 넘거나 넘지 못하는 수준에 머물게 된다.&#34;

독점: 위즈덤트리 &#34;고금리 장기화 속 가치주 투자로 이동, 관세 우려는 과장&#34;

Carter Bankshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARE#NASDAQ">CARE</a>) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.24 by 54.17 percent. This is a 1950 percent increase over losses of $(0.02) per share from the same period last year.

Earnings

News

CARE

Carter Bankshares Q4 Adj $0.37 Beats $0.24 Estimate

WIIM

BANC

Bank of California shares are trading higher after the company reported better-than-expected Q4 EPS results.

Biotech

General

ATXS

Astria Therapeutics Initiates Phase 1a Trial Of STAR-0310 For Treatment Of Atopic Dermatitis

Cass Information Sys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CASS#NASDAQ">CASS</a>) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.21 by 57.14 percent. This is a 45.9 percent decrease over earnings of $0.61 per share from the same period last year. The company reported quarterly sales of $50.37 million which beat the analyst consensus estimate of $49.48 million by 1.80 percent. This is a 0.72 percent decrease over sales of $50.74 million the same period last year.

CASS

Cass Information Sys Q4 EPS $0.33 Beats $0.21 Estimate, Sales $50.37M Beat $49.48M Estimate

Heritage Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HFWA#NASDAQ">HFWA</a>) reported quarterly earnings of $0.51 per share which beat the analyst consensus estimate of $0.45 by 13.33 percent. This is a 15.91 percent increase over earnings of $0.44 per share from the same period last year. The company reported quarterly sales of $57.053 million which missed the analyst consensus estimate of $60.685 million by 5.98 percent. This is a 12.48 percent increase over sales of $50.724 million the same period last year.

Earnings Beats

Earnings Misses

HFWA

Heritage Financial Q4 2024 Adj. EPS $0.51 Beats $0.45 Estimate, Sales $57.053M Miss $60.685M Estimate

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">143.00</td>
<td align="right">0.82</td>
<td align="right">0.57</td>
<td>7.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">140.99</td>
<td align="right">0.74</td>
<td align="right">0.52</td>
<td>22.7K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">78.45</td>
<td align="right">0.13</td>
<td align="right">0.16</td>
<td>402</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">50.49</td>
<td align="right">0.08</td>
<td align="right">0.15</td>
<td>56.0K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>Real Estate Select Sector SPDR Fund (The)</td>
<td align="right">41.11</td>
<td align="right">0.01</td>
<td align="right">0.02</td>
<td>478</td>
</tr>
</tbody>
</table>
<h3>Losers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">239.73</td>
<td align="right">-1.66</td>
<td align="right">-0.69</td>
<td>12.2K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)</td>
<td>The Communication Services Select Sector SPDR Fund</td>
<td align="right">98.71</td>
<td align="right">-0.54</td>
<td align="right">-0.55</td>
<td>1.1K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">229.38</td>
<td align="right">-0.65</td>
<td align="right">-0.29</td>
<td>415</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">77.18</td>
<td align="right">-0.04</td>
<td align="right">-0.06</td>
<td>1.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>)</td>
<td>Materials Select Sector SPDR</td>
<td align="right">88.72</td>
<td align="right">-0.02</td>
<td align="right">-0.03</td>
<td>653</td>
</tr>
</tbody>
</table>
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> this sector movers alert provides traders with a compiled way to read macro-level market trends. Investors garner a particular interest in sector movers to better determine sectors that are over- or under-performing to make better investing decisions on exchange-traded funds (ETFs) or individual tickers in those sectors. 
To read more about sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

Pre-Market Outlook

Movers

XLRE

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For January 23, 2025

Freeport-McMoRan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>) reported quarterly adjusted earnings of $0.31 per share which beat the analyst consensus estimate of $0.22 by 40.91 percent. This is a 14.81 percent increase over earnings of $0.27 per share from the same period last year. The company reported quarterly sales of $5.72 billion which missed the analyst consensus estimate of $5.99 billion by 4.51 percent. This is a 3.13 percent decrease over sales of $5.91 billion the same period last year.

Freeport-McMoRan Q4 Adj $0.31 Beats $0.22 Estimate, Sales $5.72B Miss $5.99B Estimate

Barclays analyst Alex Scott maintains Prudential Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRU#NYSE">PRU</a>) with a Equal-Weight and raises the price target from $127 to $128.

Price Target

Analyst Ratings

Barclays Maintains Equal-Weight on Prudential Financial, Raises Price Target to $128

LiveOne Surpasses 600,000 Tesla Users, Says 275,000 Are Ad-Supported Users

Barclays analyst Lauren Lieberman maintains Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) with a Equal-Weight and raises the price target from $155 to $159.

Barclays Maintains Equal-Weight on Procter & Gamble, Raises Price Target to $159

NOVAGOLD RESOURCES INC. ("NOVAGOLD" or "the Company") ((NYSE American, TSX:<a href="https://www.benzinga.com/stock/NG#TSX">NG</a>) today filed its 2024 fiscal year-end report and provided an update on its Tier One1 gold development project, Donlin Gold, which NOVAGOLD owns equally with Barrick Gold Corporation ("Barrick").
Details of the financial results for the year ended November 30, 2024, are presented in the consolidated financial statements and annual report on Form 10-K filed on January 23, 2025 which is available on the Company's website at <a href="http://www.novagold.com/">www.novagold.com</a>, on SEDAR+ at <a href="http://www.sedarplus.ca/">www.sedarplus.ca</a>, and on EDGAR at <a href="http://www.sec.gov/">www.sec.gov</a>. All amounts are in U.S. dollars unless otherwise stated.
As detailed in the above filings, NOVAGOLD held a strong treasury of approximately $101 million in cash and term deposits as of November 30, 2024, and reported net annual cash expenditures of $24.5 million — including $12.4 million to fund NOVAGOLD's share of the Donlin Gold project and $17.7 million in corporate general and administrative costs, below its 2024 expenditure guidance of $31.2 million. As NOVAGOLD is a development-stage company with no production, the Company reported earnings of ($45.6) million and earnings per share of ($0.14) for the 2024 fiscal year, reflecting expenditures in line with budget.

Guidance

NOVAGOLD Announces $101M Treasury As Of Nov 2024; Reports $24.5M Cash Expenditures; ($0.14) EPS For 2024 Fiscal Year

Electronic Arts Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EA#NASDAQ">EA</a>) reported preliminary financial results for the third quarter on Wednesday.
EA said it previously anticipated mid-single-digit growth in live services net bookings, but now projects a mid-single-digit decline largely due to a slowdown in Global Football.
The Global Football franchise experienced a slowdown in the quarter as early momentum faded, the company said. Separately, Dragon Age only engaged approximately 1.5 million players during the quarter, about 50% lower than the company's expectations.
"During Q3, we continued to deliver high-quality games and experiences across our portfolio; however, Dragon Age and EA SPORTS FC 25 underperformed our net bookings expectations," said Andrew Wilson, CEO of EA.
EA shares fell 0.7% to close at $142.35 on Wednesday.
These analysts made changes to their price targets on EA following earnings announcement.
<ul>
<li>BMO Capital analyst Brian Pitz downgraded Electronic Arts from Outperform to Market Perform and lowered the price target from $160 to $145.</li>
<li>B of A Securities analyst Omar Dessouky downgraded Electronic Arts from Buy to Neutral and lowered the price target from $170 to $130.</li>
<li>Raymond James analyst Andrew Marok downgraded the rating for Electronic Arts from Outperform to Market Perform.</li>
</ul>
Considering buying EA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="599" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23080717/image-173-1024x599.png" alt="" class="wp-image-746743" style="width:525px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23080717/image-173-1024x599.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23080717/image-173-300x175.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23080717/image-173-768x449.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23080717/image-173.png 1106w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43126364/jim-cramer-this-tech-stock-is-a-buy-amd-is-a-great-company">Jim Cramer: AMD Is A &#8216;Great&#8217; Company, Hold Onto Dow Inc.</a></li>
</ul>

Markets

These Analysts Cut Their Forecasts On Electronic Arts After Preliminary Q3 Results

Barclays analyst David Anderson maintains Halliburton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAL#NYSE">HAL</a>) with a Equal-Weight and lowers the price target from $32 to $30.

Barclays Maintains Equal-Weight on Halliburton, Lowers Price Target to $30

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

UPXI

Upexi Establishes Digital Currency Holding Company; Board Agrees To Make Investment In Portfolio Of Crypto Including Bitcoin

First Mid Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FMBH#NASDAQ">FMBH</a>) reported quarterly earnings of $0.87 per share which beat the analyst consensus estimate of $0.82 by 6.1 percent. This is a 7.45 percent decrease over earnings of $0.94 per share from the same period last year. The company reported quarterly sales of $58.95 million which met the analyst consensus estimate. This is a 2.59 percent increase over sales of $57.46 million the same period last year.

FMBH

First Mid Bancshares Q4 Adj $0.87 Beats $0.82 Estimate, Sales $58.95M Inline

GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>)&nbsp;shares are trading higher premarket on Thursday after it reported&nbsp;fourth-quarter&nbsp;adjusted revenue growth of&nbsp;16%&nbsp;year-over-year to&nbsp;$9.879 billion&nbsp;and GAAP revenue of&nbsp;$10.812 <a target="_blank" href="https://www.geaerospace.com/sites/default/files/geaerospace_webcast_pressrelease_01232025.pdf" rel="noreferrer noopener">billion</a>. The analyst consensus was&nbsp;$9.604 billion.
Commercial Engines &amp; Services&nbsp;revenue was $7.650 billion&nbsp;(+19%&nbsp;Y/Y) and Defense &amp; Propulsion Technologies&nbsp;revenue totaled $2.523 billion&nbsp;(+4%&nbsp;Y/Y).
Total orders increased&nbsp;46%&nbsp;Y/Y to&nbsp;$15.5 billion, with Commercial Engines &amp; Services&nbsp;+50% Y/Y&nbsp;and Defense &amp; Propulsion Technologies&nbsp;+22% Y/Y.
GE Aerospace&#8217;s adjusted operating profit margin expanded 450 bps to&nbsp;20.1%, with an adjusted operating profit of&nbsp;$1.988 billion, up&nbsp;49%&nbsp;in the quarter.
Adjusted EPS for the quarter was&nbsp;$1.32 (+103%&nbsp;Y/Y), <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">beating the consensus of&nbsp;$1.04</a>.
GE Aerospace&#8217;s cash from operating activities for the fiscal year stood at&nbsp;$5.8 billion&nbsp;(+26%), while adjusted free cash flow rose&nbsp;28%.
The company repurchased shares worth more than $6 billion in 2024. Also, it disclosed share repurchase plans of $7 billion in 2025, while raising the dividend by 30%, subject to Board approval.
2025 Guidance: GE Aerospace&nbsp;expects adjusted revenue growth in the low double digits and adjusted EPS of&nbsp;$5.10 &#8211; 5.45<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener"> vs. the&nbsp;$5.22&nbsp;consensus</a>.
The company expects adjusted operating profit of&nbsp;$7.8 billion&nbsp;–&nbsp;$8.2 billion&nbsp;and adjusted Free Cash Flow of&nbsp;$6.3 billion&nbsp;–&nbsp;$6.8 billion.
GE Aerospace Chairman and CEO H. Lawrence Culp, Jr. said, &#8220;Looking to 2025, we expect double-digit revenue and EPS growth with greater than 100% free cash flow conversion. Guided by FLIGHT DECK, our proprietary lean operating model, I&#8217;m confident in our ability to accelerate output and deliver for our customers.&#8221;
Investors can gain exposure to the stock via&nbsp;TCW Transform Systems ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NETZ#NYSE">NETZ</a>)and&nbsp;iShares U.S. Aerospace &amp; Defense ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ITA#BATS">ITA</a>).
Price Action: GE shares are up 8.04% at $203.51 premarket at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43152748/sp-500-hits-new-record-fear-among-us-investors-eases-but-fear-greed-index-remains-in-fear-zone" target="_blank" rel="noreferrer noopener">S&amp;P 500 Hits New Record As Netflix Reports Strong Results: Investor Sentiment Improves But Greed Index Remains In &#8216;Fear&#8217; Zone</a></li>
</ul>

Equities

Large Cap

Dividends

Buybacks

iShares Dow Jones US Aerospace & Defense Index Fund

Engine No. 1 ETF Trust Engine No. 1 Transform Climate ETF

NETZ

GE Aerospace Q4 Earnings: EPS Beat, Dividend And Stock Buyback Hike, Strong FY25 Outlook And More

Barclays analyst Julian Mitchell maintains GE Vernova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) with a Overweight and raises the price target from $420 to $487.

Barclays Maintains Overweight on GE Vernova, Raises Price Target to $487

Approval of three important therapies for dementia, oncology and gastrointestinal disease
Granted 180-day exclusivity for memantine/donepezil extended-release capsules
Tentative approval of rifaximin, a product for treating IBS-D
Amneal Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMRX#NASDAQ">AMRX</a>) ("Amneal" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has approved memantine/donepezil 14-10 mg and 28-10 mg extended-release capsules, which references Abbvie's NAMZARIC&#xAE;, and Everolimus 2 mg, 3 mg and 5 mg extended-release capsules, which references Novartis' AFINITOR DISPERZ&#xAE;. In addition, the FDA has granted tentative approval to Amneal's rifaximin 550 mg oral tablets, which references Bausch Health's XIFAXAN&#xAE;. The FDA approval was tentative as this product is involved in litigation.
Memantine/donepezil extended-release capsules are indicated for the treatment of moderate to severe dementia of the Alzheimer's type. The product has launched with 180-day exclusivity.
Everolimus tablets for oral suspension are indicated for the treatment of Tuberous Sclerosis Complex (TSC)-Associated Subependymal Giant Cell Astrocytoma (SEGA) in adult and pediatric patients aged one year or older. This launch increases the supply of an oncology product that has limited suppliers.
Rifaximin 550 mg oral tablets are indicated for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults.

AMRX

Amneal Announces FDA Approval For Dementia And Oncology Therapies, Tentative Approval For IBS-D Drug; 180-Day Exclusivity For Memantine/Donepezil

Events

ALXO

ALX Oncology Announces Oral Presentation At 2025 ASCO Gastrointestinal Cancers Symposium Today

For speculative traders seeking exposure to daily sentiment swings, the new year seemingly offers plenty of ammunition. With President Donald Trump entering his second term, the outspoken leader wasted no time reshaping U.S. policy with a<a href="https://www.benzinga.com/government/regulations/25/01/43084601/trump-day-1-executive-order-tsunami-incoming-heres-what-hes-signing-first"> flurry of executive orders</a>. These actions encompass a range of subjects, including energy, immigration, inflation, social policies and trade.
Thanks to a unique vision that sharply contrasts with the prior Biden administration, several sectors rose to the forefront. Perhaps the most prominent example is the cryptocurrency market. Ever since Trump's electoral victory last November, the ecosystem for blockchain-derived assets has been invigorated. Throughout the campaign trail, the former real estate mogul openly and enthusiastically<a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43062997/exclusive-how-donald-trumps-crypto-plans-will-bitcoin-xrp-solana"> embraced decentralized digital assets</a>.
In addition, President Trump's pro-business mandates – which notably include deregulation and lower corporate taxes – may reinvigorate a risk-on framework. Emerging industries, such as quantum computing and space economy specialists, have been clear beneficiaries of the conducive environment. These factors combine with a greater emphasis on building out<a href="https://www.benzinga.com/25/01/42862503/3-digital-infrastructure-etfs-in-focus-as-trump-reveals-billion-dollar-data-center-construction-plan"> digital infrastructures</a> to create plenty of upside opportunities for investors to find.
Still, not everything is leaning toward the northward direction. Given the sharp pivot from the prior administration, there are bound to be losers. Among them sit market segments tied to renewable energy. In particular,<a href="https://www.benzinga.com/trading-ideas/movers/25/01/43147598/ev-stocks-are-falling-today-whats-going-on"> shares of electric vehicle stocks faltered recently</a> amid radical changes under Trump 2.0. With the president promising to "drill, baby, drill," the<a href="https://www.benzinga.com/government/regulations/25/01/43097430/trumps-drill-baby-drill-era-begins-oil-prices-tumble-us-energy-stocks-edge-up"> move toward hydrocarbons</a> has caused anxiety among green energy proponents.
Moreover, elements outside of direct executive control may cause the equities arena to stumble. Perhaps most worryingly,<a href="https://www.benzinga.com/trading-ideas/25/01/43064849/4-stocks-to-buy-for-higher-for-longer-interest-rates"> interest rates could stay elevated</a> for longer than desired, in large part due to a red-hot labor market. When these factors are seen in conjunction with a<a href="https://www.benzinga.com/economics/macro-economic-events/25/01/42896114/us-2025-recession-odds-plummet-good-news-or-warning-sign"> potential misreading of broader risk</a>, investors could be facing a surprisingly dynamic ecosystem.
The Direxion ETFs: To put it simply, the market could be liable to move in any direction, depending on the prevailing winds. With that in mind, the most adventurous and aggressive investors may consider ultra-leveraged exchange-traded funds. For the optimists, the Direxion Daily Small Cap Bull 3X Shares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TNA#NYSE">TNA</a>) seek the daily investment results of 300% of the performance of the Russell 2000 index.
With exposure to the TNA ETF, traders can potentially enjoy significant upside without having to buy call options. Instead, market participants can pick up units of TNA, similar to any publicly traded enterprise. In the same vein, bearish speculators can acquire units of the Direxion Daily Small Cap Bear 3X Shares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TZA#NYSE">TZA</a>) rather than needing to resort to purchasing put options.
While the Direxion 3X ETFs are convenient, investors should note the volatility risks involved in these financial products. As Direxion's<a href="https://www.direxion.com/product/daily-small-cap-bull-bear-3x-etfs"> website</a> states, these leveraged ETFs are designed for trading exposure lasting no longer than one day.
The TNA ETF: Although the chart for the Daily Small Cap Bull ETF is a choppy affair, anticipation of a much more business-friendly environment has bolstered sentiment recently.
<ul>
<li>Over the trailing one-month period, TNA gained almost 8% of value, driving the price action above the 200-day moving average (DMA).</li>
<li>Technical resistance lies at the 50 DMA, which currently stands a bit above $48. For the bulls, this will be the next natural target.</li>
</ul>
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXf2tMb0MYkL5HZuEUDtUKPeZwaP9R5TSmRfBmockq0UJfV14B2-jV3iOd2PMgBfcrd3y4mYg8_V6PqVgu54CBeeufT8yoxyiyBY75eXgZBSc4VfiQXyFUze6jReRwoJn-4ejiKF8Q?key=U_Y0u8R0Y_cA_5nvA0CDLRBd" alt="" /></figure>
The TZA ETF: A volatile canvas, the Daily Small Cap Bear ETF has struggled over the past 52 weeks, losing more than 45%. However, an economic shock could revitalize the inverse fund.
<ul>
<li>For proponents of the TZA ETF, it's vital for the bear fund to keep its head above the psychologically and technically significant $10 level.</li>
<li>Right now, the 50 DMA provides support for TZA. Moving forward, the upside target is where the 200 DMA stands at a few clicks above $15.</li>
</ul>
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXcTGV5-x-BFejfGg3BKhhEbig7erIttWKGg-gXPRU-aAQut2XepCP7dn1qpfHH4zSqsdiNgU8l6wzmdBoiLpQMeueWHPDdBxOPDLkI1G6ZP4TjUr7mVBr7zMJej1Gz8hexIytKG0g?key=U_Y0u8R0Y_cA_5nvA0CDLRBd" alt="" /></figure>
Featured image by <a href="https://pixabay.com/users/geralt-9301/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=8477673">Gerd Altmann</a> from <a href="https://pixabay.com/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=8477673">Pixabay</a>.

Short Ideas

Technicals

Trump 2.0 Presents Both Promise And Pitfalls For Direxion's Small Cap Bull And Bear Funds

What Works In Non-U.S. Equities? High Quality

Weekly Market Pulse: The Fed Declares Victory

Chart Of The Week: Dollar Index Moving Lower

WisdomTree International Hedged Quality Dividend Growth Fund declares quarterly distribution of $0.1050

IHDG: A Sensible Stock Strategy And A Bullish Bet On The Dollar

Will International Stocks Outperform Again?

International Quality Dividend Growth: Annual Rebalance Summary

New Administration Motivates Fresh Look At International Investments

IHDG: Wrapping Up A Soft Year For Foreign Quality Stocks

WisdomTree International Hedged Quality Dividend Growth Fund declares quarterly distribution of $0.2964

Comments

WisdomTree International Hedged Quality Dividend Growth Fund

매도 수량

WisdomTree International Hedged Quality Dividend Growth Fund (ARCA:IHDG), 공매도 수량 보고

뉴스

파트너 / 기고자

벤징가 글로벌